1-17 of 17
Authors: Juan Macias
Journal Article
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens Free
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 11, November 2023, Pages 2696–2701, https://doi.org/10.1093/jac/dkad285
Published: 19 September 2023
Journal Article
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice Open Access
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 10, October 2023, Pages 2591–2596, https://doi.org/10.1093/jac/dkad278
Published: 06 September 2023
Journal Article
HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study Open Access
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_5, November 2019, Pages v39–v46, https://doi.org/10.1093/jac/dkz455
Published: 29 November 2019
Journal Article
Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care Open Access
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_5, November 2019, Pages v31–v38, https://doi.org/10.1093/jac/dkz454
Published: 29 November 2019
Journal Article
Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series Open Access
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_5, November 2019, Pages v24–v30, https://doi.org/10.1093/jac/dkz453
Published: 29 November 2019
Journal Article
Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis Free
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 9, September 2018, Pages 2435–2443, https://doi.org/10.1093/jac/dky234
Published: 02 July 2018
Journal Article
A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 4, April 2013, Pages 915–921, https://doi.org/10.1093/jac/dks488
Published: 12 December 2012
Journal Article
Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 12, December 2011, Pages 2838–2842, https://doi.org/10.1093/jac/dkr385
Published: 27 September 2011
Journal Article
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 11, November 2011, Pages 2605–2614, https://doi.org/10.1093/jac/dkr357
Published: 07 September 2011
Journal Article
Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 6, June 2011, Pages 1351–1353, https://doi.org/10.1093/jac/dkr091
Published: 17 March 2011
Journal Article
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 6, June 2011, Pages 1346–1350, https://doi.org/10.1093/jac/dkr083
Published: 10 March 2011
Journal Article
Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 10, October 2010, Pages 2204–2211, https://doi.org/10.1093/jac/dkq272
Published: 22 July 2010
Journal Article
Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis Get access
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 1, January 2009, Pages 178–183, https://doi.org/10.1093/jac/dkn429
Published: 24 October 2008
Journal Article
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone Get access
Journal of Antimicrobial Chemotherapy, Volume 62, Issue 6, December 2008, Pages 1365–1373, https://doi.org/10.1093/jac/dkn420
Published: 13 October 2008
Journal Article
Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 59, Issue 1, January 2007, Pages 87–91, https://doi.org/10.1093/jac/dkl447
Published: 09 November 2006
Journal Article
Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C Get access
Journal of Antimicrobial Chemotherapy, Volume 58, Issue 1, July 2006, Pages 140–146, https://doi.org/10.1093/jac/dkl214
Published: 23 May 2006
Journal Article
Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy Free
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 4, April 2005, Pages 417–419, https://doi.org/10.1093/jac/dkh555
Published: 01 April 2005
